PRDX1 has been shown to repress nasopharyngeal carcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition in vitro by inactivating the PI3K/AKT/TRAF1 pathway [45]. Here, PRDX1 is linked to nasopharyngeal carcinoma.